Anatomy-Based Fitting in Unexperienced Cochlear Implant Users (ABFmulti)

December 11, 2023 updated by: Universitair Ziekenhuis Brussel
Severe to profound hearing loss affects 0,8% of the global population. For these people, a conventional hearing aid often does not provide sufficient benefit. However, these people can benefit from a cochlear implant (CI). A CI needs to be individually programmed (fitted) for each recipient. A fitting "map" is defined as a set of electrical parameters that are individually adapted to a recipient's needs to achieve optimal sound perception. At present, most CI recipients are fitted with a default frequency allocation map that doesn't take individual variability in size and shape of the cochlea into account. In this study, a fitting strategy based on the post-operative CT scan, that will allow the audiologist to set a frequency-band distribution for CI fitting that may be more closely aligned to the natural tonotopic frequency distribution of a normal hearing cochlea, will be evaluated.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Brussel, Belgium, 1090
        • Recruiting
        • UZ Brussel
        • Contact:
          • Vedat Topsakal, Prof
        • Contact:
          • Emilie Heuninck

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age ≥ 18 years
  • Post-lingual onset of severe to profound sensory-neural hearing loss in the implanted ear(s)
  • Post-operative Computed Tomography (CT) scan of the CI electrode available
  • Pre-operative result of pure-tone audiometry, speech test in quiet and in noise available
  • Subject implanted with MED-EL cochlear implant(s)
  • Subjects received a Flex28, FlexSoft or Standard electrode
  • Subject planned to receive a SONNET 2 or RONDO 3 audio processor on the newly implanted side
  • Audio processor not yet activated on the newly implanted side
  • The most apical active electrode contact has to be inserted at least 450°
  • Minimum of 10 active channels can be activated
  • Fluent in the language of the test centre
  • Signed and dated Informed Consent Form (ICF) before the start of any study-specific procedure

Exclusion Criteria:

  • Lack of compliance with any inclusion criteria
  • Electric Acoustic Stimulation (EAS) user (user of an EAS audio processor)
  • Implanted with C40+, C40X and C40C
  • Implanted with an Auditory Brainstem Implant (ABI) or Split electrode array
  • Anything that, in the opinion of the Investigator, would place the subject at increased risk or pre-clude the subject's full compliance with or completion of the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Default CI fitting
Programming of cochlear implant speech processor according to standard clinical care
Programming of cochlear implant speech processor according to standard clinical care
Active Comparator: Anatomy-based CI fitting
Programming of cochlear implant speech processor with anatomy-based fitting
Programming of cochlear implant speech processor with anatomy-based fitting

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Speech recognition test in quiet (S0): percentage correctly identified phonemes
Time Frame: 3 months post-activation
3 months post-activation
Speech recognition test in quiet (S0): percentage correctly identified phonemes
Time Frame: 6 months post-activation
6 months post-activation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Speech recognition test in noise (S0N0): the speech reception threshold in dB SNR
Time Frame: 3 months post-activation
3 months post-activation
Speech recognition test in noise (S0N0): the speech reception threshold in dB SNR
Time Frame: 6 months post-activation
6 months post-activation
Result of the pitch matching test: frequency difference in semitones
Time Frame: 3 months post-activation
3 months post-activation
Result of the pitch matching test: frequency differences in semitones
Time Frame: 6 months post-activation
6 months post-activation
Result of the perception of timbre test: Score on Visual Analog Scale (VAS)
Time Frame: 3 months post-activation
Patients have to rate the timbre on a visual analog scale (VAS) ranging from 0 to 10, where a higher score reflects a better outcome.
3 months post-activation
Result of the perception of timbre test: Score on Visual Analog Scale (VAS)
Time Frame: 6 months post-activation
Patients have to rate the timbre on a visual analog scale (VAS) ranging from 0 to 10, where a higher score reflects a better outcome.
6 months post-activation
Result of the consonance and dissonance rating test: Plot of pleasantness over frequency interval and modulation measure
Time Frame: 3 months post-activation
3 months post-activation
Result of the consonance and dissonance rating test: Plot of pleasantness over frequency interval and modulation measure
Time Frame: 6 months post-activation
6 months post-activation
Result of the speech contrast discrimination test: Psychometric function of phoneme categorization
Time Frame: 3 months post-activation
3 months post-activation
Result of the speech contrast discrimination test: Psychometric function of phoneme categorization
Time Frame: 6 months post-activation
6 months post-activation
Patient reported outcome- Hearing Implant Sound Quality Index (HISQUI): Total score and classification of self-perceived auditory benefit
Time Frame: 1 day visit (At the activation of the sound processor)
1 day visit (At the activation of the sound processor)
Patient reported outcome- Hearing Implant Sound Quality Index (HISQUI): Total score and classification of self-perceived auditory benefit
Time Frame: 3 months post-activation
3 months post-activation
Patient reported outcome- Hearing Implant Sound Quality Index (HISQUI): Total score and classification of self-perceived auditory benefit
Time Frame: 6 months post-activation
6 months post-activation
Datalogging data: Average numbers of hours per day
Time Frame: 2 weeks post-activation
2 weeks post-activation
Datalogging data: Average numbers of hours per day
Time Frame: 1 months post-activation
1 months post-activation
Datalogging data: Average numbers of hours per day
Time Frame: 3 months post-activation
3 months post-activation
Datalogging data: Average numbers of hours per day
Time Frame: 6 months post-activation
6 months post-activation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Vedat Topsakal, Prof., UZB-VUB

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 30, 2022

Primary Completion (Estimated)

January 1, 2025

Study Completion (Estimated)

January 1, 2025

Study Registration Dates

First Submitted

June 2, 2022

First Submitted That Met QC Criteria

July 8, 2022

First Posted (Actual)

July 11, 2022

Study Record Updates

Last Update Posted (Actual)

December 12, 2023

Last Update Submitted That Met QC Criteria

December 11, 2023

Last Verified

December 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sensorineural Hearing Loss

Clinical Trials on Default CI fitting

Subscribe